Sebela Pharmaceuticals Announces New Division Named Sebela Women's Health
November 15, 2022
Sebela Pharmaceuticals Appoints Victor Parker as Chief Commercial Officer
October 24, 2022
Sebela Pharmaceuticals Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
October 19, 2022
Sebela Pharmaceuticals Announces U.S. Launch of SUTAB® Tablets, An Alternative to Liquid Colonoscopy Preparation
January 5, 2021
Sebela Pharmaceuticals acquires U.S. drug firm Braintree Laboratories
May 12, 2018
